Rona Singer Weinberg

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia”.

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.01.437942

N/A

0DataRank · unranked

10 citations

Kristina Kay Gonzales-Wartz, Deli Huang, Meng Yuan, Mary Peterson, Janie Liang +35 more

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

Cell Host & Microbe(2022)10.1016/j.chom.2022.10.010

N/A

0DataRank · unranked

65 citations

Linghang Peng, Ting-Hui Lin, Courtney Tucker, Chang‐Chun D. Lee, Cong Yu +39 more

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Blood(2022)10.1182/blood.2022017326

N/A

0DataRank · unranked

64 citations

Lavanya Bezavada, Jeremy Chase Crawford, Sandeep Gurbuxani, Anitria Cotton, Guolian Kang +10 more

Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms

Nature Communications(2022)10.1038/s41467-022-29381-7

N/A

0DataRank · unranked

25 citations

Jeremy Q. Wen, Ewa M. Kościuczuk, Frank Eckerdt, Elspeth M. Beauchamp, Chidera V. Oku +14 more

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

JCI Insight(2022)10.1172/jci.insight.156534

N/A

0DataRank · unranked

6 citations

Raajit K. Rampal, Cing Siang Hu, Joseph Tripodi, Noushin Farnoud, Bruce Petersen +12 more

Broadly neutralizing antibodies target the coronavirus fusion peptide

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.11.487879

N/A

0DataRank · unranked

24 citations

Courtney Tucker, Linghang Peng, Chang‐Chun D. Lee, Ting-Hui Lin, Meng Yuan +37 more

Type 1 interferon perturbates clonal competition by reshaping human blood development

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.28.509751

N/A

0DataRank · unranked

2 citations

Danielle Isakov, Shira Rosenberg, Miguel Quijada-Álamo, Mirca Saurty-Seerunghen, Sara Moein +31 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101259

N/A

0DataRank · unranked

13 citations

Larry L. Luchsinger, Rona Singer Weinberg, Alexandra Jimenez, Emeline Masson Frenet, Wouter Van’t Hof +6 more

Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0010

N/A

0DataRank · unranked

7 citations

Ewa M. Kościuczuk, Mariafausta Fischietti, Ricardo E. Perez, Guang Yang, Frank Eckerdt +9 more

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Science Translational Medicine(2021)10.1126/scitranslmed.abj5413

N/A

0DataRank · unranked

138 citations

Kristina Kay Gonzales-Wartz, Deli Huang, Meng Yuan, Mary Peterson, Janie Liang +35 more